Hormonal Contraceptives Global Market Report 2023 Hormonal Contraceptives Global Market Report 2023 – By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Other Products), By Distribution Channel (Drug Stores, Gynaecology/ Fertility Clinics, ECommerce, Other Distribution Channels), By Hormones (ProgestinOnly, Combined Hormones), By End Users (Hospitals, Homecare Settings, Gynaecology Centers, Clinics, Ambulatory surgical centers) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Hormonal contraceptive refers to a method of birth control that stops pregnancy using hormones. There are numerous types. Some can be undone, while others are irreversible. Some varieties can also aid in the prevention of STDs. For further insights on the hormonal contraceptives market, request a sample here

The hormonal contraceptives market growth is aided by increased awareness about the benefits and use of contraceptives. However, some hormonal contraceptives market restraints include the growing use of biologics in place of traditional chemical drugs. For further insights on the hormonal contraceptives market, request a sample here

The hormonal contraceptives market is expected to reach $14.56 billion in 2027 at a rate of 1.4%. For further insights on the hormonal contraceptives market, request a sample here

The global hormonal contraceptives market is segmented as
1) By Product: Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Other Products
2) By End Users: Hospitals, Homecare Settings, Gynaecology Centers, Clinics, Ambulatory surgical centers
3) By Hormones: Progestin-Only, Combined Hormones
4) By Distribution Channel: Drug Stores, Gynaecology/ Fertility Clinics, E-Commerce, Other Distribution Channels
For further insights on the hormonal contraceptives market, request a sample here

North America was the largest region in the hormonal contraceptives market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the hormonal contraceptives market are, Bayer AG, Merck & Co. Inc., Pfizer, Allergan, Afaxys Inc., Teva Pharma Industries Ltd., Agile Therapeutics, HLL Lifecare Limited, Lupin Pharmaceuticals Inc., Piramal Healthcare Limited, Cipla Limited , Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Amgen, Ansell Limited, Church & Dwight Co, Johnson & Johnson, Mayer Laboratories, Famy care, Mylan Laboratories. For further insights on the hormonal contraceptives market, request a sample here.

Major trends influencing the hormonal contraceptives market include innovating to manufacture chewable low-dose oral contraceptives that reduce side effects. The chewable contraceptive initiative was an attempt to reduce side effects while at the same time making it easier for the patients to get into a daily regimen of using this contraceptive. The pill is already being sold as an over-the-counter product. For further insights on the hormonal contraceptives market, request a sample here.

For detailed insights on the major opportunities and strategies in the hormonal contraceptives market, request a sample here.

For detailed insights on hormonal contraceptives market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the hormonal contraceptives industry, request a sample here.

For detailed insights on the key dynamics influencing the hormonal contraceptives market growth and SWOT analysis of the hormonal contraceptives industry, request a sample here.